Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study

Aims. Genes of the 5-lipoxygenase pathway are compelling candidates for atherosclerosis. We hypothesize that polymorphisms in ALOX12, ALOX15, ALOX5, and ALOX5AP genes are associated with subclinical atherosclerosis in multiple vascular beds. Methods. Families with two or more siblings with type 2 diabetes and their nondiabetic siblings were studied as part of the Diabetes Heart Study (DHS). European American diabetic (n = 828) and nondiabetic (n = 170) siblings were genotyped for SNPs in the ALOX12, ALOX15, ALOX5, and ALOX5AP genes. Subclinical measures of atherosclerosis (IMT, coronary (CorCP), carotid (CarCP) and aortic (AorCP) calcified plaque) were obtained. Results. Associations were observed between ALOX12 with CorCP, ALOX5 with CorCP, AorCP, and IMT, and ALOX5AP with CorCP and CarCP, independent of known epidemiologic risk factors. Further, lipoxygenase pathway SNPs that were associated with measures of atherosclerosis were associated with markers of inflammation (CRP, ICAM-1) and calcification (MGP). Conclusions. Polymorphisms within ALOX12, ALOX5, and ALOX5AP are genetically associated with subclinical atherosclerosis and with biomarkers of disease in families with type 2 diabetes. These results suggest that variants in lipoxygenase pathway genes may have pleiotropic effects on multiple components that determine risk of cardiovascular disease.

[1]  D. Kiel,et al.  Matrix Gla Protein Is Associated With Risk Factors for Atherosclerosis but not With Coronary Artery Calcification , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Vilmundur Gudnason,et al.  A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction , 2006, Nature Genetics.

[3]  G. Hansson,et al.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Funk,et al.  The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. , 2005, Biochimica et biophysica acta.

[5]  C. Serhan.  Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  C. Serhan,et al.  Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  D. Gudbjartsson,et al.  Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. , 2005, JAMA.

[8]  U. Thorsteinsdóttir,et al.  Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. , 2005, American journal of human genetics.

[9]  T. Klockgether,et al.  Heritability of Carotid Artery Atherosclerotic Lesions: An Ultrasound Study in 154 Families , 2005, Stroke.

[10]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[11]  A. Ghazalpour,et al.  Thematic Review toward a Biological Network for Atherosclerosis Human Studies , 2022 .

[12]  A. Lusis,et al.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.

[13]  C. Langefeld,et al.  Race-Specific Relationships Between Coronary and Carotid Artery Calcification and Carotid Intimal Medial Thickness , 2004, Stroke.

[14]  R. Natarajan,et al.  12/15-Lipoxygenase Activity Mediates Inflammatory Monocyte/Endothelial Interactions and Atherosclerosis in Vivo* , 2004, Journal of Biological Chemistry.

[15]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[16]  C. Clish,et al.  Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.

[17]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[18]  C. Hedrick,et al.  Increased Production of 12/15 Lipoxygenase Eicosanoids Accelerates Monocyte/Endothelial Interactions in Diabetic db/db Mice* , 2003, Journal of Biological Chemistry.

[19]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[21]  L. Almasy,et al.  Genetic Basis of Variation in Carotid Artery Plaque in the San Antonio Family Heart Study , 2002, Stroke.

[22]  Daniel Steinberg,et al.  Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.

[23]  D. Rader,et al.  Selective Interleukin-12 Synthesis Defect in 12/15-Lipoxygenase-deficient Macrophages Associated with Reduced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia* , 2002, The Journal of Biological Chemistry.

[24]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[25]  D. Kiel,et al.  Evidence for Heritability of Abdominal Aortic Calcific Deposits in the Framingham Heart Study , 2002, Circulation.

[26]  C. Langefeld,et al.  Heritability of Carotid Artery Intima-Medial Thickness in Type 2 Diabetes , 2002, Stroke.

[27]  C. H. Liu,et al.  Heritability of Subclinical Atherosclerosis in Latino Families Ascertained Through a Hypertensive Parent , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Patrick Royston,et al.  Autosomal Genome-Wide Scan for Coronary Artery Calcification Loci in Sibships at High Risk for Hypertension , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[29]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[30]  Lei Zhao,et al.  12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice , 2001, Circulation.

[31]  A. Lusis,et al.  Genetic Locus in Mice That Blocks Development of Atherosclerosis Despite Extreme Hyperlipidemia , 2001, Circulation research.

[32]  A. Tall,et al.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Rader,et al.  Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E—Deficient Mice , 2001, Circulation.

[34]  C. Serhan,et al.  Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[35]  C. Langefeld,et al.  Familial aggregation of coronary artery calcium in families with type 2 diabetes. , 2001, Diabetes.

[36]  M. Trevisan,et al.  Arterial abnormalities in the offspring of patients with premature myocardial infarction. , 2000, The New England journal of medicine.

[37]  J. George,et al.  Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[38]  D. Rader,et al.  Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. , 1999, The Journal of clinical investigation.

[39]  P. Libby,et al.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. , 1997, The American journal of pathology.

[40]  J. Cornhill,et al.  Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.

[41]  R. Duggirala,et al.  Genetic basis of variation in carotid artery wall thickness. , 1996, Stroke.

[42]  O. Rådmark.  Arachidonate 5-lipoxygenase. , 2002, Journal of lipid mediators and cell signalling.

[43]  Shozo Yamamoto,et al.  Mammalian lipoxygenases: molecular structures and functions. , 1992, Biochimica et biophysica acta.

[44]  C. Glass,et al.  Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[46]  P. Hopkins,et al.  Human genetics and coronary heart disease: a public health perspective. , 1989, Annual review of nutrition.

[47]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.